The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory ...
Oral and poster presentations highlight robust and high-quality immune responses following administration of novel arenaviral therapeutic vaccines in preclinical setting Alternating 2-vector therapy ...
A new study has shown promising results for a nasal COVID-19 vaccine, according to researchers at the Institute of Virology at Freie Universität Berlin in Germany. When two doses of the live nasal ...
Russia recently rolled out the single-dose Sputnik Light COVID-19 vaccine — also known as Gam-COVD-Vac — for wide circulation. However, some global health authorities argue that more tests are ...
In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development ...
In a recently published article in Frontiers in Immunology, scientists have discussed the possibilities of developing oral replicon-based mRNA vaccines against severe acute respiratory syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback